Skip to content
healthcare.dev

Irbesartan and Hydrochlorothiazide

NDC 72162-2317, Irbesartan and Hydrochlorothiazide, tablet, from Bryant Ranch Prepack.

Product NDC
72162-2317
Status
Listed
Labeler
Bryant Ranch Prepack
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203072
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72162-2317 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRBESARTAN150 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
72162-2317-37216223170330 TABLET in 1 BOTTLE (72162-2317-3)
72162-2317-97216223170990 TABLET in 1 BOTTLE (72162-2317-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/53ce6e4f-db3a-4789-8bef-1e459fa78b79

Use it

Look up 72162-2317 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72162-2317 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72162-2317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.